COCP Cocrystal Pharma, Inc. - Common Stock
$1,14
السعر · مايو 20, 2026
البيانات الأساسية اعتبارًا من مايو 15, 2026
نطاق 52 أسبوعًا
$1–$3
15% of range
تقييم المحللين
BUY
8 analysts
السعر المستهدف
$8
+602% upside
P/E (TTM)
-1.3
ROE
-151.4%
هامش صافي الربح
—
COCP لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$1.14
القيمة السوقية
$14M
P/E (TTM)
-1.3
ربح السهم (آخر 12 شهرًا)
$-0.78
الإيرادات (آخر 12 شهرًا)
—
عائد التوزيعات
—
ROE
-151.4%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$1 – $3
COCP مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
—
2019-12-31
→
2020-12-31
ربح السهم
$-0.78
2016-12-31
→
2025-12-31
التدفق النقدي الحر
$-8M
2018-12-31
→
2025-12-31
الهوامش
—
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
COCP
متوسط الأقران
P/E (TTM)
-1.3
42.1
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
6.8
6.4
P/B (السعر / القيمة الدفترية)
2.1
2.1
Price / FCF (السعر / التدفق النقدي الحر)
-1.6
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
COCP
متوسط الأقران
ROA (العائد على الأصول)
-76.2%
-71.6%
ROE
-151.4%
-62.0%
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
COCP
متوسط الأقران
Current Ratio (النسبة الحالية)
3.7
2.3
Quick Ratio (النسبة السريعة)
3.2
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
COCP
متوسط الأقران
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
COCP
متوسط الأقران
COCP توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
8 محللين
- شراء قوي 2 25,0%
- شراء 5 62,5%
- احتفاظ 1 12,5%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
3 محللين · 2026-05-19
الوسيط
$8.00
← أقل من جميع الأهداف
$1.14
منخفض
$6.00
مرتفع
$10.00
السعر المستهدف الوسيط
$8.00
+601,8%
السعر المستهدف المتوسط
$8.00
+601,8%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.10%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 31 مارس، 2026 | $-0.17 | $-0.15 | -0.02% |
| 31 ديسمبر، 2025 | $-0.17 | $-0.18 | 0.01% |
| 30 سبتمبر، 2025 | $-0.19 | $-0.21 | 0.02% |
| 30 يونيو، 2025 | $-0.20 | $-0.31 | 0.11% |
| 31 مارس، 2025 | $-0.23 | $-0.52 | 0.29% |
| 31 ديسمبر، 2024 | $-0.32 | $-0.54 | 0.22% |
مقارنة النظراء المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| COCP | $14M | -1.3 | — | — | -151.4% | — |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | — |
| JUNS | $35M | -4.1 | — | -39662.8% | 3516.1% | 80.6% |
| CTXR | — | -0.4 | — | — | — | — |
| CVKD | $16M | -1.0 | — | — | -376.2% | — |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| HOTH | $15M | -1.1 | — | — | -156.9% | — |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $2M | $7M | · | · | · | · | · | |
| R&D Expense | $5M | $13M | $15M | $12M | $9M | $6M | $4M | $5M | $6M | $102M | $47M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $6M | $5M | $6M | $5M | $4M | $2M | $4M | $7M | $2M | |
| Operating Expenses | $9M | $18M | $19M | $39M | $14M | $12M | $55M | $63M | $8M | $106M | $54M | $6M | |
| Operating Income | $-9M | $-18M | $-19M | $-39M | $-14M | $-10M | $-48M | $-63M | $-8M | $-106M | $-54M | $-6M | |
| Interest Expense | · | · | $-640.0K | $2.0K | $4.0K | $8.0K | $19.0K | $58.0K | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | $-7.0K | $126.0K | $180.0K | $96.0K | |
| Other Non-op | $188.0K | $374.0K | $575.0K | $-8.0K | $36.0K | $-62.0K | $237.0K | $294.0K | $769.0K | $2M | $-11M | $6M | |
| Pretax Income | $-9M | $-19M | · | · | · | $-10M | $-48M | $-63M | $-7M | $-104M | $-65M | $-151.0K | |
| Income Tax | · | · | · | · | · | · | · | $-14M | $-7M | $-29M | $-15M | $-52.0K | |
| Net Income | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| EPS (Basic) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | $-0.16 | · | · | · | $-0.03 | $-3.18 | $-2.40 | $0.00 | |
| EPS (Diluted) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | · | · | $-0.03 | $-3.30 | $-2.40 | $-0.01 | |
| Shares (Basic) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | 7,364,000 | · | 31,859 | 28,009 | 24,126,000 | 23,518,000 | 21,011,000 | 326,779,000 | |
| Shares (Diluted) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | · | · | · | · | 24,126,000 | 23,533,000 | 21,011,000 | 327,753,000 | |
| EBITDA | $-9M | $-18M | · | $-39M | $-14M | $-10M | $-48M | $-63M | · | · | · | · |
الميزانية العمومية 24
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $26M | $37M | $59M | $33M | $7M | $3M | $748.0K | $4M | $9M | $4M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Receivables | · | · | · | · | · | $556.0K | $644.0K | · | $1.0K | $21.0K | $32.0K | $122.0K | |
| Prepaid Expense | $328.0K | $430.0K | $2M | $2M | $568.0K | $399.0K | $169.0K | $191.0K | $105.0K | $517.0K | $441.0K | $144.0K | |
| Current Assets | $8M | $12M | $29M | $40M | $59M | $34M | $8M | $3M | $2M | $5M | $10M | $6M | |
| PP&E (Net) | $93.0K | $153.0K | $271.0K | $342.0K | $453.0K | $591.0K | $431.0K | $384.0K | $119.0K | $280.0K | $430.0K | $284.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $983.0K | $1M | $1M | $1M | $949.0K | |
| Goodwill | · | · | · | · | $19M | $19M | $19M | $65M | $65M | $65M | $65M | $65M | |
| Total Assets | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Accounts Payable | $890.0K | $2M | $1M | $614.0K | $578.0K | $657.0K | $2M | $616.0K | $494.0K | $563.0K | · | $299.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $563.0K | $3M | $693.0K | |
| Current Liabilities | $2M | $2M | $3M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $7M | $9M | |
| Capital Leases | $1M | $2M | $2M | $57.0K | $291.0K | $345.0K | $523.0K | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $14M | $20M | $50M | $65M | |
| Total Liabilities | $3M | $4M | $5M | $1M | $2M | $2M | $3M | $2M | $16M | $23M | $57M | $74M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $50M | $65M | |
| Common Stock | $13.0K | $10.0K | $10.0K | $8.0K | $8.0K | $71.0K | $36.0K | $30.0K | $24.0K | $24.0K | $694.0K | $123.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $243M | $240M | $229M | $19M | |
| Retained Earnings | $-342M | $-333M | $-316M | $-298M | $-259M | $-245M | $-235M | $-187M | $-138M | $-137M | $-63M | $-12M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $0 | $236.0K | |
| Stockholders' Equity | $6M | $10M | $26M | $40M | $78M | $53M | $26M | $67M | $105M | $102M | $168M | $7M | |
| Liabilities + Equity | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Shares Outstanding | 13,784,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 70,439,000 | 35,150,000 | 29,938,000 | 24,275,000 | 23,801,000 | 694,396,000 | 122,494 |
التدفق النقدي 12
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.0K | $126.0K | $189.0K | $185.0K | $190.0K | $157.0K | $98.0K | $6.0K | $101.0K | $201.0K | $192.0K | $199.0K | |
| Stock-based Comp | $270.0K | $643.0K | $801.0K | $855.0K | $724.0K | $662.0K | $351.0K | $562.0K | $614.0K | $548.0K | $3M | $38.0K | |
| Deferred Tax | · | · | · | · | · | · | $-14M | $-14M | $-7M | $-29M | $-15M | $-54.0K | |
| Operating Cash Flow | $-8M | $-16M | $-15M | $-21M | $-13M | $-10M | $-2M | $-8M | $-7M | $-15M | $-10M | $-6M | |
| CapEx | $12.0K | $8.0K | $118.0K | $74.0K | $52.0K | $240.0K | $145.0K | $28.0K | $40.0K | $51.0K | $339.0K | $5.0K | |
| Investing Cash Flow | $-12.0K | $-8.0K | $-118.0K | $-74.0K | $-52.0K | $-240.0K | $-145.0K | $1M | $-40.0K | $3.0K | $-262.0K | $6M | |
| Stock Issued | $154.0K | · | $4M | · | $39M | $36M | $7M | $8M | $3M | $9M | $16M | · | |
| Net Stock Activity | $154.0K | · | · | · | $39M | $36M | $7M | $8M | · | · | · | · | |
| Financing Cash Flow | $5M | · | $4M | $-27.0K | $38M | $36M | $6M | $9M | $4M | $9M | $16M | $3M | |
| Net Change in Cash | $-3M | $-16M | $-11M | $-22M | $26M | $26M | $5M | $2M | $-3M | $-6M | $5M | $3M | |
| Free Cash Flow | $-8M | $-16M | · | $-22M | $-13M | $-10M | $-2M | $-8M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | $-8M | · | · | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| Net Margin | · | · | · | · | · | -479.0% | -733.8% | 84565.5% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | -479.0% | -733.8% | 107982.8% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| ROA | -76.2% | -78.3% | · | -64.6% | -21.2% | -23.3% | -99.2% | -51.6% | · | · | · | · | |
| ROE | -151.4% | -157.5% | · | -86.8% | -17.9% | -18.8% | -99.9% | -55.2% | · | · | · | · | |
| ROIC | · | · | · | · | · | · | · | -73.7% | · | · | · | · |
السيولة والملاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.8 | · | 33.0 | 38.4 | 25.0 | 3.6 | 1.9 | · | · | · | · | |
| Quick Ratio | 3.2 | 4.1 | · | 30.6 | 38.0 | 24.7 | 3.5 | 1.7 | · | · | · | · | |
| Interest Coverage | · | · | · | -19414.5 | -3555.2 | -1198.2 | · | -1084.9 | · | · | · | · |
الكفاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.1 | -0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 3.4 | 20.4 | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | $7M | $78.0K | $78.0K | $78.0K | · | · | |
| Net Income TTM | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| Market Cap | $14M | $21M | · | $16M | $760M | $1.15B | $211M | $1.29B | · | · | · | · | |
| P/E | -1.3 | -1.2 | -0.9 | -0.4 | · | · | -85.7 | 1440.0 | -2400.0 | -42.5 | -133.5 | -15120.0 | |
| P/S | 6.8 | 10.3 | · | 8.0 | 380.9 | 570.8 | 32.1 | 16581.0 | · | · | · | · | |
| P/B | 2.1 | 2.2 | · | 0.4 | 9.8 | 21.9 | 8.2 | 19.3 | · | · | · | · | |
| P / Tangible Book | 2.1 | 2.2 | 0.7 | 0.4 | 13.0 | 34.4 | · | · | · | · | · | · | |
| P / Cash Flow | -1.6 | -1.2 | · | -0.7 | -59.8 | -116.9 | -134.9 | -156.0 | · | · | · | · | |
| P / FCF | -1.6 | -1.2 | · | -0.7 | -59.5 | -114.2 | -123.5 | -155.5 | · | · | · | · | |
| Earnings Yield | -79.6% | -85.2% | -108.7% | -244.6% | · | · | -1.2% | 0.07% | -0.04% | -2.4% | -0.75% | -0.01% |
قائمة الدخل 14
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $225.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $1M | $2M | $954.0K | $1M | $1M | $2M | $3M | $4M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $2M | |
| SG&A Expense | $1M | $862.0K | $1M | $986.0K | $981.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Operating Expenses | $3M | $2M | $2M | $2M | $2M | $3M | $5M | $5M | $4M | $5M | $4M | $4M | $5M | $5M | $6M | $24M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | $-24M | |
| Interest Expense | · | · | · | · | · | · | · | · | $-220.0K | · | $-320.0K | $-140.0K | · | $0 | $1.0K | · | |
| Other Non-op | $57.0K | $55.0K | $40.0K | $53.0K | $40.0K | $-36.0K | $103.0K | $105.0K | $202.0K | $202.0K | $278.0K | $173.0K | $-78.0K | $1.0K | $-6.0K | · | |
| Income Tax | $0 | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | $-5M | $-6M | $-24M | |
| EPS (Basic) | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | $-0.70 | $-3.00 | |
| EPS (Diluted) | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.54 | $-0.70 | $-3.00 | |
| Shares (Basic) | 13,786,000 | -20,049,000 | 10,991,000 | 10,174,000 | 10,174,000 | -20,348,000 | 10,174,000 | 10,174,000 | 10,174,000 | -18,710,000 | 10,153,000 | 10,065,000 | 8,143,000 | -16,286,000 | 8,143,000 | 8,143,000 | |
| Shares (Diluted) | 13,786,000 | -20,049,000 | 10,991,000 | 10,174,000 | 10,174,000 | -20,348,000 | 10,174,000 | 10,174,000 | 10,174,000 | -18,710,000 | 10,153,000 | 10,065,000 | 8,143,000 | 0 | 8,143,000 | 8,143,000 | |
| EBITDA | $-2M | · | $-2M | $-2M | $-2M | · | $-5M | $-5M | $-4M | · | $-4M | $-4M | $-5M | · | $-6M | $-24M |
الميزانية العمومية 16
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $7M | $8M | $5M | $7M | $10M | $13M | $18M | $22M | $26M | $30M | $32M | $34M | $37M | $42M | $51M | |
| Prepaid Expense | $418.0K | $328.0K | $465.0K | $282.0K | $385.0K | $430.0K | $509.0K | $365.0K | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $488.0K | |
| Current Assets | $6M | $8M | $9M | $7M | $9M | $12M | $14M | $20M | $24M | $29M | $32M | $36M | $37M | $40M | $45M | $52M | |
| PP&E (Net) | $81.0K | $93.0K | $106.0K | $107.0K | $127.0K | $153.0K | $181.0K | $211.0K | $244.0K | $271.0K | $252.0K | $305.0K | $338.0K | $342.0K | $378.0K | $363.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | $2M | $2M | |
| Total Assets | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | $52M | |
| Accounts Payable | $1M | $890.0K | $745.0K | $856.0K | $808.0K | $2M | $859.0K | $2M | $1M | $1M | $568.0K | $1M | $3M | $614.0K | $897.0K | $616.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $1M | $2M | $3M | |
| Capital Leases | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | · | $10.0K | $27.0K | $57.0K | $119.0K | $177.0K | |
| Total Liabilities | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $2M | $2M | $3M | $1M | $2M | $3M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $8.0K | $8.0K | $98.0K | |
| Retained Earnings | $-345M | $-342M | $-340M | $-338M | $-336M | $-333M | $-330M | $-325M | $-320M | $-316M | $-311M | $-307M | $-303M | $-298M | $-293M | $-288M | |
| Stockholders' Equity | $4M | $6M | $8M | $5M | $7M | $10M | $13M | $17M | $23M | $26M | $31M | $35M | $35M | $40M | $44M | $49M | |
| Liabilities + Equity | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | $52M | |
| Shares Outstanding | 13,787,000 | 13,784,000 | 13,041,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 8,143,000 | 97,469,000 |
التدفق النقدي 9
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12.0K | $13.0K | $13.0K | $21.0K | $25.0K | $28.0K | $30.0K | $33.0K | $35.0K | $40.0K | $53.0K | $47.0K | $49.0K | $48.0K | $47.0K | $44.0K | |
| Stock-based Comp | $84.0K | $56.0K | $48.0K | $84.0K | $82.0K | $85.0K | $253.0K | $148.0K | $157.0K | $158.0K | $173.0K | $179.0K | $291.0K | $159.0K | $216.0K | $241.0K | |
| Operating Cash Flow | $-2M | $-2M | $-1M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-6M | $-3M | $-5M | $-9M | $-4M | |
| CapEx | · | $0 | · | · | · | $0 | $0 | $0 | $8.0K | $59.0K | $0 | $14.0K | $45.0K | $12.0K | · | · | |
| Investing Cash Flow | · | $0 | · | · | · | $0 | $0 | $0 | $-8.0K | $-59.0K | $0 | $-14.0K | $-45.0K | $-12.0K | · | · | |
| Stock Issued | · | $0 | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | · | |
| Financing Cash Flow | · | $1M | · | · | · | · | · | · | · | $0 | $0 | $4M | $-7.0K | $-7.0K | $-7.0K | $-7.0K | |
| Net Change in Cash | $-2M | $-704.0K | $3M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-2M | $-3M | $-5M | $-9M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-3M | · | · | · |
الربحية 5
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1021.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -25.4% | · | -15.4% | -13.7% | -12.4% | · | -20.2% | -18.5% | -12.3% | · | -10.6% | -9.4% | -9.2% | · | -8.9% | -34.9% | |
| ROE | -40.3% | · | -20.1% | -18.1% | -15.4% | · | -22.8% | -20.5% | -13.8% | · | -11.2% | -9.9% | -9.6% | · | -9.1% | -36.4% |
السيولة والملاءة 3
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | · | 5.8 | 3.7 | 4.6 | · | 7.3 | 7.4 | 10.3 | · | 16.7 | 22.5 | 11.8 | · | 27.7 | 18.3 | |
| Quick Ratio | 2.1 | · | 5.1 | 2.6 | 3.6 | · | 6.7 | 6.8 | 9.2 | · | 15.5 | 20.4 | 10.8 | · | 26.0 | 18.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 18.9 | · | 13.9 | 31.0 | · | · | -5694.0 | · |
الكفاءة 1
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | |
| Net Income TTM | $-9M | · | $-11M | $-15M | $-17M | · | $-18M | $-18M | $-17M | · | $-19M | $-39M | $-40M | · | $-38M | $-36M | |
| Market Cap | $14M | · | $16M | $15M | $14M | · | $18M | $24M | $14M | · | $19M | $24M | $16M | · | $28M | $480M | |
| P/E | -1.3 | · | -1.1 | -1.0 | -0.9 | · | -1.0 | -1.3 | -0.8 | · | -0.9 | -0.5 | · | · | · | · | |
| P/S | · | · | 8.2 | 7.6 | 7.2 | · | 9.0 | 11.9 | 7.1 | · | 9.5 | 12.2 | 8.1 | · | 14.2 | 240.3 | |
| P/B | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | 0.7 | 0.5 | · | 0.6 | 9.7 | |
| P / Tangible Book | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | 0.7 | 0.5 | · | 0.6 | 9.7 | |
| P / Cash Flow | -6.0 | · | · | · | -4.9 | · | · | · | -3.2 | · | · | · | -5.2 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | -3.2 | · | · | · | -5.1 | · | · | · | |
| Earnings Yield | -78.2% | · | -88.8% | -97.3% | -115.5% | · | -103.4% | -74.7% | -132.1% | · | -115.5% | -198.7% | · | · | · | · |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| صافي الدخل | $-9M | $-18M | $-18M | $-39M | $-14M |
| EPS المخفف | $-0.78 | $-1.72 | $-1.87 | $-4.77 | — |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 3.7 | 4.8 | — | 33.0 | 38.4 |
| النسبة السريعة | 3.2 | 4.1 | — | 30.6 | 38.0 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-8M | $-16M | — | $-22M | $-13M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.